57/100B423.40
USD
-5.65
(-1.31%)
Market Open
Last updated: · Delayed 15 min
Fair value401.93Plus+5%262Price 423.40501
Q4 FY2026 · Earnings report
EPS estimate 2.08Revenue estimate 49.38B
Q4 FY2026 · Earnings report
EPS estimate 2.08Revenue estimate 49.38B
Elevance Health revenue 1998–2026What is revenue? Revenue is the money a company brings in from selling its goods and services over a period, before any costs. It is the top line of the income statement.
Elevance Health's revenue in Q3 FY2026, the three months to 30 September 2026, was 51.43B USD, up 1.4% on the same quarter a year before. Elevance Health's revenue over the last twelve months was 201.83B USD, up 3.6% on the twelve months before. In fiscal year 2025 it was 199.13B USD, up 12.6% on the year before.
Last updated 12 Nov 2026 · Next report 27 Jan 2027
Revenue
Growth
| Fiscal year | Period ending | Revenue | Growth | Gross profit | Net income |
|---|---|---|---|---|---|
| TTM | 30 Sept 2026 | 201.83B | +3.60% | 73.78B | 5.14B |
| FY2025 | 31 Dec 2025 | 199.13B | +12.62% | 50.90B | 5.66B |
| FY2024 | 31 Dec 2024 | 176.81B | +3.19% | 49.24B | 5.98B |
| FY2023 | 31 Dec 2023 | 171.34B | +9.42% | 47.01B | 5.99B |
| FY2022 | 31 Dec 2022 | 156.60B | +12.95% | 39.95B | 5.89B |
| FY2021 | 31 Dec 2021 | 138.64B | +13.76% | 35.99B | 6.10B |
| FY2020 | 31 Dec 2020 | 121.87B | +16.94% | 33.82B | 4.57B |
| FY2019 | 31 Dec 2019 | 104.21B | +13.15% | 22.43B | 4.81B |
| FY2018 | 31 Dec 2018 | 92.11B | +2.29% | 20.21B | 3.75B |
| FY2017 | 31 Dec 2017 | 90.04B | +5.96% | 17.80B | 3.84B |
| FY2016 | 31 Dec 2016 | 84.98B | +7.24% | 18.14B | 2.47B |
| FY2015 | 31 Dec 2015 | 79.24B | +7.19% | 18.12B | 2.56B |
| FY2014 | 31 Dec 2014 | 73.92B | +3.94% | 17.07B | 2.57B |
| FY2013 | 31 Dec 2013 | 71.12B | +15.58% | 14.89B | 2.65B |
| FY2012 | 31 Dec 2012 | 61.54B | +1.20% | 13.32B | 2.66B |
| FY2011 | 31 Dec 2011 | 60.80B | +3.34% | 13.16B | 2.65B |
| FY2010 | 31 Dec 2010 | 58.84B | -4.55% | 13.91B | 2.89B |
| FY2009 | 31 Dec 2009 | 61.64B | -1.30% | 14.65B | 4.75B |
| FY2008 | 31 Dec 2008 | 62.46B | +1.73% | 14.25B | 2.49B |
| FY2007 | 31 Dec 2007 | 61.39B | +7.69% | 14.96B | 3.35B |
| FY2006 | 31 Dec 2006 | 57.01B | +26.26% | 14.49B | 3.09B |
| FY2005 | 31 Dec 2005 | 45.15B | +116.91% | 0.00 | 2.46B |
| FY2004 | 31 Dec 2004 | 20.82B | +24.26% | 0.00 | 960.10M |
| FY2003 | 31 Dec 2003 | 16.75B | +26.38% | 16.75B | 774.30M |
| FY2002 | 31 Dec 2002 | 13.26B | +26.91% | 13.26B | 549.10M |
| FY2001 | 31 Dec 2001 | 10.44B | -39.68% | 10.44B | 342.20M |
| FY2000 | 31 Dec 2000 | 17.31B | +40.19% | 17.31B | 226.00M |
| FY1999 | 31 Dec 1999 | 12.35B | +11.55% | 12.35B | 44.90M |
| FY1998 | 31 Dec 1998 | 11.07B | — | 11.07B | 172.40M |
| Quarter | Period ending | Revenue | Growth on a year before | Gross profit | Net income |
|---|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 51.43B | +1.42% | 8.01B | 1.37B |
| Q2 FY2026 | 30 Jun 2026 | 50.47B | +1.40% | 44.98B | 1.46B |
| Q1 FY2026 | 31 Mar 2026 | 50.18B | +2.64% | 9.10B | 1.76B |
| Q4 FY2025 | 31 Dec 2025 | 49.75B | +9.47% | 11.68B | 547.00M |
| Q3 FY2025 | 30 Sept 2025 | 50.71B | +12.33% | 12.57B | 1.19B |
| Q2 FY2025 | 30 Jun 2025 | 49.78B | +14.04% | 13.07B | 1.74B |
| Q1 FY2025 | 31 Mar 2025 | 48.89B | +14.83% | 13.58B | 2.18B |
| Q4 FY2024 | 31 Dec 2024 | 45.44B | +6.55% | 11.94B | 418.00M |
| Q3 FY2024 | 30 Sept 2024 | 45.15B | +5.36% | 12.20B | 1.02B |
| Q2 FY2024 | 30 Jun 2024 | 43.65B | -0.06% | 13.07B | 2.30B |
| Q1 FY2024 | 31 Mar 2024 | 42.58B | +0.96% | 12.03B | 2.25B |
| Q4 FY2023 | 31 Dec 2023 | 42.65B | +6.81% | 11.31B | 856.00M |
| Q3 FY2023 | 30 Sept 2023 | 42.85B | +7.29% | 12.24B | 1.29B |
| Q2 FY2023 | 30 Jun 2023 | 43.67B | +13.05% | 12.07B | 1.85B |
| Q1 FY2023 | 31 Mar 2023 | 42.17B | +10.70% | 11.39B | 1.99B |
| Q4 FY2022 | 31 Dec 2022 | 39.93B | +9.15% | 9.73B | 865.00M |
| Q3 FY2022 | 30 Sept 2022 | 39.94B | +11.49% | 10.52B | 1.60B |
| Q2 FY2022 | 30 Jun 2022 | 38.63B | +14.12% | 9.84B | 1.64B |
| Q1 FY2022 | 31 Mar 2022 | 38.10B | +17.63% | 9.86B | 1.79B |
| Q4 FY2021 | 31 Dec 2021 | 36.58B | +14.95% | 9.04B | 1.14B |
| Q3 FY2021 | 30 Sept 2021 | 35.82B | +14.97% | 9.18B | 1.51B |
| Q2 FY2021 | 30 Jun 2021 | 33.85B | +15.67% | 9.09B | 1.79B |
| Q1 FY2021 | 31 Mar 2021 | 32.39B | +9.33% | 8.69B | 1.67B |
| Q4 FY2020 | 31 Dec 2020 | 31.82B | +16.12% | 7.74B | 551.00M |
| Q3 FY2020 | 30 Sept 2020 | 31.16B | +16.81% | 8.24B | 222.00M |
| Q2 FY2020 | 30 Jun 2020 | 29.26B | +14.91% | 9.72B | 2.28B |
| Q1 FY2020 | 31 Mar 2020 | 29.62B | +20.09% | 8.13B | 1.52B |
| Q4 FY2019 | 31 Dec 2019 | 27.41B | +17.26% | 6.02B | 934.00M |
| Q3 FY2019 | 30 Sept 2019 | 26.67B | +14.72% | 5.92B | 1.18B |
| Q2 FY2019 | 30 Jun 2019 | 25.47B | +10.99% | 5.10B | 1.14B |
| Q1 FY2019 | 31 Mar 2019 | 24.67B | +9.44% | 5.38B | 1.55B |
| Q4 FY2018 | 31 Dec 2018 | 23.37B | +3.05% | 4.44B | 425.00M |
| Q3 FY2018 | 30 Sept 2018 | 23.25B | +3.68% | 5.07B | 960.00M |
| Q2 FY2018 | 30 Jun 2018 | 22.94B | +2.39% | 5.22B | 1.05B |
| Q1 FY2018 | 31 Mar 2018 | 22.54B | +0.05% | 5.49B | 1.31B |
| Q4 FY2017 | 31 Dec 2017 | 22.68B | +4.39% | 0.00 | 1.23B |
| Q3 FY2017 | 30 Sept 2017 | 22.43B | +4.72% | 0.00 | 746.90M |
| Q2 FY2017 | 30 Jun 2017 | 22.41B | +4.43% | 0.00 | 855.30M |
| Q1 FY2017 | 31 Mar 2017 | 22.53B | +11.03% | 0.00 | 1.01B |
| Q4 FY2016 | 31 Dec 2016 | 21.73B | +7.62% | 0.00 | 368.40M |
| Q3 FY2016 | 30 Sept 2016 | 21.41B | +7.60% | 0.00 | 617.80M |
| Q2 FY2016 | 30 Jun 2016 | 21.46B | +7.20% | — | 780.60M |
| Q1 FY2016 | 31 Mar 2016 | 20.29B | +6.49% | — | 703.00M |
| Q4 FY2015 | 31 Dec 2015 | 20.19B | +6.34% | — | 180.90M |
| Q3 FY2015 | 30 Sept 2015 | 19.90B | +7.25% | — | 654.80M |
| Q2 FY2015 | 30 Jun 2015 | 20.02B | +8.35% | — | 859.10M |
| Q1 FY2015 | 31 Mar 2015 | 19.05B | +6.67% | — | 865.20M |
| Q4 FY2014 | 31 Dec 2014 | 18.98B | +8.04% | — | 506.70M |
| Q3 FY2014 | 30 Sept 2014 | 18.56B | +3.93% | — | 630.90M |
| Q2 FY2014 | 30 Jun 2014 | 18.47B | +4.43% | — | 731.10M |
| Q1 FY2014 | 31 Mar 2014 | 17.86B | +1.61% | — | 701.00M |
| Q4 FY2013 | 31 Dec 2013 | 17.57B | +13.10% | — | 148.20M |
| Q3 FY2013 | 30 Sept 2013 | 17.86B | +16.30% | — | 656.20M |
| Q2 FY2013 | 30 Jun 2013 | 17.69B | +14.82% | — | 800.10M |
| Q1 FY2013 | 31 Mar 2013 | 17.58B | +14.02% | — | 885.20M |
| Q4 FY2012 | 31 Dec 2012 | 15.54B | +1.43% | — | 464.20M |
| Q3 FY2012 | 30 Sept 2012 | 15.35B | -0.29% | — | 691.20M |
| Q2 FY2012 | 30 Jun 2012 | 15.41B | +2.03% | — | 643.60M |
| Q1 FY2012 | 31 Mar 2012 | 15.42B | +3.50% | — | 856.50M |
| Q4 FY2011 | 31 Dec 2011 | 15.32B | +4.57% | — | 335.30M |
| Q3 FY2011 | 30 Sept 2011 | 15.40B | +5.67% | — | 683.20M |
| Q2 FY2011 | 30 Jun 2011 | 15.10B | +4.64% | — | 701.60M |
| Q1 FY2011 | 31 Mar 2011 | 14.89B | -1.18% | — | 926.60M |
| Q4 FY2010 | 31 Dec 2010 | 14.65B | -23.09% | — | 548.80M |
| Q3 FY2010 | 30 Sept 2010 | 14.57B | -5.53% | — | 739.10M |
| Q2 FY2010 | 30 Jun 2010 | 14.43B | -6.37% | — | 722.40M |
| Q1 FY2010 | 31 Mar 2010 | 15.07B | -0.46% | — | 876.80M |
| Q4 FY2009 | 31 Dec 2009 | 19.05B | +26.39% | — | 2.74B |
| Q3 FY2009 | 30 Sept 2009 | 15.43B | +3.10% | — | 730.20M |
| Q2 FY2009 | 30 Jun 2009 | 15.41B | -1.62% | — | 693.50M |
| Q1 FY2009 | 31 Mar 2009 | 15.14B | -2.64% | — | 580.40M |
| Q4 FY2008 | 31 Dec 2008 | 15.07B | -3.16% | — | 331.40M |
| Q3 FY2008 | 30 Sept 2008 | 14.96B | -1.84% | — | 820.70M |
| Q2 FY2008 | 30 Jun 2008 | 15.67B | +2.61% | — | 750.50M |
| Q1 FY2008 | 31 Mar 2008 | 15.55B | +3.09% | — | 588.10M |
| Q4 FY2007 | 31 Dec 2007 | 15.56B | +6.91% | — | 859.10M |
| Q3 FY2007 | 30 Sept 2007 | 15.24B | +5.49% | — | 868.00M |
| Q2 FY2007 | 30 Jun 2007 | 15.27B | +7.74% | — | 835.20M |
| Q1 FY2007 | 31 Mar 2007 | 15.09B | +9.03% | — | 783.10M |
| Q4 FY2006 | 31 Dec 2006 | 14.56B | +27.32% | — | 801.10M |
| Q3 FY2006 | 30 Sept 2006 | 14.45B | +29.51% | — | 810.80M |
| Q2 FY2006 | 30 Jun 2006 | 14.17B | +27.11% | — | 751.20M |
| Q1 FY2006 | 31 Mar 2006 | 13.84B | +26.46% | — | 731.80M |
| Q4 FY2005 | 31 Dec 2005 | 11.43B | +67.30% | — | 652.00M |
| Q3 FY2005 | 30 Sept 2005 | 11.16B | +132.09% | — | 640.70M |
| Q2 FY2005 | 30 Jun 2005 | 11.15B | +141.95% | — | 559.40M |
| Q1 FY2005 | 31 Mar 2005 | 10.94B | +139.26% | — | 611.70M |
| Q4 FY2004 | 31 Dec 2004 | 6.83B | +59.11% | — | 184.50M |
| Q3 FY2004 | 30 Sept 2004 | 4.81B | +12.80% | — | 242.10M |
| Q2 FY2004 | 30 Jun 2004 | 4.61B | +11.99% | — | 237.90M |
| Q1 FY2004 | 31 Mar 2004 | 4.57B | +11.55% | — | 295.60M |
| Q4 FY2003 | 31 Dec 2003 | 4.29B | +7.63% | — | 208.80M |
| Q3 FY2003 | 30 Sept 2003 | 4.26B | +19.06% | — | 196.50M |
| Q2 FY2003 | 30 Jun 2003 | 4.11B | +41.87% | — | 177.30M |
| Q1 FY2003 | 31 Mar 2003 | 4.10B | +45.79% | — | 191.70M |
| Q4 FY2002 | 31 Dec 2002 | 3.99B | +49.89% | — | 171.90M |
| Q3 FY2002 | 30 Sept 2002 | 3.58B | +34.38% | — | 171.20M |
| Q2 FY2002 | 30 Jun 2002 | 2.90B | — | — | 106.20M |
| Q1 FY2002 | 31 Mar 2002 | 2.81B | -81.92% | — | 99.80M |
| Q4 FY2001 | 31 Dec 2001 | 2.66B | — | — | 87.70M |
| Q3 FY2001 | 30 Sept 2001 | 2.66B | — | — | 111.50M |
| Q1 FY2001 | 31 Mar 2001 | 15.55B | — | 0.00 | 588.10M |
Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
Elevance Health revenue growth by segment
Q3 FY2026 against Q3 FY2025
Health Benefits43.36B
+2.6%
Carelon Services19.31B
+5.4%
Elevance Health revenue by segment over time
Health Benefits Carelon Services Other Government Business Commercial Specialty Business IngenioRx
See also:Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement
Common questions about Elevance Health's revenue
Source: Financial Modeling Prep